Brief: Enanta Pharmaceuticals Inc QTRLY Loss Per Share $1.05
Enanta Pharmaceuticals Inc ENTA.O :
* : QTRLY LOSS PER SHARE $1.05
* Q1 EARNINGS PER SHARE VIEW $-1.35 -- LSEG IBES DATA
Source text: ID:n0000950170-25-017035
Further company coverage: ENTA.O
Recent news on Enanta Pharmaceuticals
See all newsEnanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royalties
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Enanta Pharmaceuticals Q1 revenue beats estimates